Nevertheless, since the primary task of this project was to prove that the genetic defect causing LPL deficiency is curable, these problems can be left for future research on cell therapy, which will lead to the development of a safe and efficient vector. Here, LPL is linked to hyperinsulinemic hypoglycemia, familial, 4.